Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Chan

Showing results (251-260 of 271) with videos related to

Pageof 28
Sort By:
Nature Biotechnology|November 2, 2021
Improved prediction of immune checkpoint blockade efficacy across multiple cancer typesDiego Chowell, Seong-Keun Yoo, Cristina Valero, et al.
Journal of the National Cancer Institute|July 30, 2020
Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic EfficacyKenneth L Pitter, Dana L Casey, Yue C Lu, et al.
Nature Genetics|December 1, 2015
Integrated genomic characterization of IDH1-mutant glioma malignant progressionHanwen Bai, Akdes Serin Harmancı, E Zeynep Erson-Omay, et al.
Oncoimmunology|May 22, 2025
Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad ConferenceFereshteh Talebi, Fabiana Gregucci, Jalal Ahmed, et al.
Nature Biotechnology|December 18, 2018
Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identificationBrendan Bulik-Sullivan, Jennifer Busby, Christine D Palmer, et al.
Nature Genetics|May 21, 2013
The mutational landscape of adenoid cystic carcinomaAllen S Ho, Kasthuri Kannan, David M Roy, et al.
Science (New York, N.Y.)|March 5, 2016
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockadeNicholas McGranahan, Andrew J S Furness, Rachel Rosenthal, et al.
Nature|November 14, 2017
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancerVinod P Balachandran, Marta Łuksza, Julia N Zhao, et al.
Cancer Discovery|June 27, 2022
A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell CarcinomaPhillip M Rappold, Lynda Vuong, Josef Leibold, et al.
Cell Reports. Medicine|June 21, 2023
Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomasMarkus Bredel, Lluís Espinosa, Hyunsoo Kim, et al.
Pageof 28

Showing results (251-260 of 271) with videos related to

Sort By:
Pageof 28
Nature Biotechnology|November 2, 2021
Improved prediction of immune checkpoint blockade efficacy across multiple cancer typesDiego Chowell, Seong-Keun Yoo, Cristina Valero, et al.
Journal of the National Cancer Institute|July 30, 2020
Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic EfficacyKenneth L Pitter, Dana L Casey, Yue C Lu, et al.
Nature Genetics|December 1, 2015
Integrated genomic characterization of IDH1-mutant glioma malignant progressionHanwen Bai, Akdes Serin Harmancı, E Zeynep Erson-Omay, et al.
Oncoimmunology|May 22, 2025
Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad ConferenceFereshteh Talebi, Fabiana Gregucci, Jalal Ahmed, et al.
Nature Biotechnology|December 18, 2018
Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identificationBrendan Bulik-Sullivan, Jennifer Busby, Christine D Palmer, et al.
Nature Genetics|May 21, 2013
The mutational landscape of adenoid cystic carcinomaAllen S Ho, Kasthuri Kannan, David M Roy, et al.
Science (New York, N.Y.)|March 5, 2016
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockadeNicholas McGranahan, Andrew J S Furness, Rachel Rosenthal, et al.
Nature|November 14, 2017
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancerVinod P Balachandran, Marta Łuksza, Julia N Zhao, et al.
Cancer Discovery|June 27, 2022
A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell CarcinomaPhillip M Rappold, Lynda Vuong, Josef Leibold, et al.
Cell Reports. Medicine|June 21, 2023
Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomasMarkus Bredel, Lluís Espinosa, Hyunsoo Kim, et al.
Pageof 28